ORY-1001, a potent and selective covalent KDM1A inhibitor, for the treatment of Acute Leukemia

2019-07-19T09:26:21Z (GMT) by tamara maes
Experiment design THP-1 H3K4me2 ChIPSeq Data after ORY-1001 treatment

Categories

Keyword(s)

License

CC BY 4.0